COVID-19 antibody study in hospitalized patients
Part of Infections, Lungs & breathing clinical trials.
This research study examines a specific type of antibody (anti-annexin A2) that may develop during COVID-19 infection. By studying hospitalized COVID-19 patients, researchers hope to understand whether these antibodies are common and what role they might play in COVID-19 illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are currently hospitalized with confirmed COVID-19 infection
- You do not have an autoimmune disease (like lupus or rheumatoid arthritis)
- You do not have chronic hepatitis B, hepatitis C, or HIV
- You are not currently taking immunosuppressive medications (drugs that weaken the immune system)
- You do not have a history of solid tumors or blood cancers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
This study follows adults who are in the hospital (including the emergency ward) with a confirmed COVID-19 infection. It aims to learn how COVID-19 affects people in the hospital and how different cases may differ over time.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This study measures how many healthcare workers have COVID antibodies (proof of past infection or immune response). Results may help estimate how widespread COVID exposure has been among hospital staff.
This study collects information from adults who are in the hospital for confirmed COVID-19. The goal is to better understand what happens during acute (early) COVID-19 and improve care.
This study collects immune cells from people who recovered from COVID-19 and may use them to boost protection against SARS-CoV-2. It’s for hospitalized patients who already show a certain level of COVID-19 fighting immune response.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.